Understand the pathophysiology of NAFLD/NASH and the associated risk factors and disease complications.
Describe the national prevalence and disease burden of NAFLD/NASH.
Discuss the typical clinical presentation and diagnostic recommendations for patients with NAFLD/NASH.
Summarize current and evolving treatment options for patients with NAFLD/NASH.
This webinar is part of a series of educational activities presented by ADCES in association with AstraZeneca-US Medical Affairs, CVMD Division. This webinar is educational in nature and contains no promotional or product information. CE credit is not available for this activity.